A Multicenter, Randomized, Single-blind, 2-Arm Intervention Study Evaluating the Adverse Events and Quality of Life After Irreversible Electroporation for the Ablation of Localized Low-Intermediate Risk Prostate Cancer. Letter

J Urol. 2023 May;209(5):846-847. doi: 10.1097/JU.0000000000003404. Epub 2023 Mar 16.
No abstract available

Publication types

  • Randomized Controlled Trial
  • Multicenter Study
  • Letter
  • Comment

MeSH terms

  • Ablation Techniques* / adverse effects
  • Electroporation
  • Humans
  • Male
  • Prostate / surgery
  • Prostatic Neoplasms* / etiology
  • Prostatic Neoplasms* / surgery
  • Quality of Life
  • Single-Blind Method